Nasal saline for allergic rhinitis: an alternative treatment method

1
LETTER TO THE EDITOR Nasal Saline for Allergic Rhinitis: An Alternative Treatment Method TURKER YILMAZ 1 , HANIFI KURTARAN 1 , AHMET KARADAG 2 and NURDAN URAS 2 From the Departments of 1 Otorhinolaryngology and 2 Pediatrics, Faculty of Medicine, Fatih University, Ankara, Turkey Sir, We have taken an interest in a recently published article in your journal by Unal et al (1). In their study, Unal et al. concluded that, in allergic rhinitis, injection of 40 units of botulinum toxin type A (BTX-A) was superior to injection of 2 ml of isotonic saline solution to both nasal cavities as placebo for the management of allergic symptoms. However, we think that the use of isotonic saline solution as placebo is inappropriate. Nasal washing with isotonic saline solution certainly facilitates nasal drainage and cleans the airway of any postnasal discharge; however, it is effective only when applied appropriately (2, 3). As described in the aforementioned studies, five dropperfuls of saline solution were applied to each nostril at least four times a day (2, 3). In the study of Unal et al., the inferior results obtained in the control group may have been due to saline solution not being applied using the technique described above. It is well known that irrigation with saline solution reduces levels of inflam- matory mediators in nasal secretions and indirectly reinforces the clinical efficacy of other treatments for chronic rhinitis. Therefore, nasal washing with saline solution is effective against pathologies of the upper respiratory tract that occur via inflammatory media- tors, namely the common cold, acute and chronic sinusitis and, in particular, chronic rhinitis (2 /6). Given all these factors, we consider that nasal washing with saline solution will be as effec- tive as BTX-A injection if the correct technique is used. REFERENCES 1. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol 2003; 123: 1060 /3. 2. Ozsoylu S. Nose drops at the common cold. Eur J Pediatr 1985; 144: 294. 3. Karadag A. Nasal saline for acute sinusitis. Pediatrics 2002; 109: 165. 4. Kurtaran H, Karadag A, Catal F, Avci Z. A reappraisal of nasal saline solution use in chronic sinusitis. Chest 2003; 124: 2036 /7. 5. Georgitis JW. Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory media- tors. Chest 1994; 106: 1487 /92. 6. Pichichero ME, Green JL, Francis AB, Marsocci SM, Murphy ML. Outcomes after judicious antibiotic use for respiratory tract infections seen in a private pediatric practice. Pediatrics 2000; 105: 753 /9. Submitted February 13, 2004; accepted March 4, 2004 Address for correspondence: Ahmet Karadag, MD Huzur Mah Ceyhun Atif Kansu Cad 343/11 Nergiz Ap TR-06460 Balgat Ankara Turkey Tel.: /90 312 212 62 62 Fax: /90 312 221 32 76 E-mail: [email protected] Acta Otolaryngol 2004; 124: 1240 # Taylor & Francis 2004. ISSN 0001-6489 DOI 10.1080/00016480410018223 Acta Otolaryngol Downloaded from informahealthcare.com by University of Pittsburgh on 07/07/14 For personal use only.

Transcript of Nasal saline for allergic rhinitis: an alternative treatment method

LETTER TO THE EDITOR

Nasal Saline for Allergic Rhinitis: An Alternative Treatment Method

TURKER YILMAZ1, HANIFI KURTARAN1, AHMET KARADAG2 and NURDAN URAS2

From the Departments of 1Otorhinolaryngology and 2Pediatrics, Faculty of Medicine, Fatih University, Ankara, Turkey

Sir,

We have taken an interest in a recently published

article in your journal by Unal et al (1). In their study,

Unal et al. concluded that, in allergic rhinitis, injection

of 40 units of botulinum toxin type A (BTX-A) was

superior to injection of 2 ml of isotonic saline solution

to both nasal cavities as placebo for the management

of allergic symptoms. However, we think that the useof isotonic saline solution as placebo is inappropriate.

Nasal washing with isotonic saline solution certainly

facilitates nasal drainage and cleans the airway of any

postnasal discharge; however, it is effective only when

applied appropriately (2, 3). As described in the

aforementioned studies, five dropperfuls of saline

solution were applied to each nostril at least four times

a day (2, 3). In the study of Unal et al., the inferiorresults obtained in the control group may have been

due to saline solution not being applied using the

technique described above. It is well known that

irrigation with saline solution reduces levels of inflam-

matory mediators in nasal secretions and indirectly

reinforces the clinical efficacy of other treatments for

chronic rhinitis. Therefore, nasal washing with saline

solution is effective against pathologies of the upperrespiratory tract that occur via inflammatory media-

tors, namely the common cold, acute and chronic

sinusitis and, in particular, chronic rhinitis (2�/6).

Given all these factors, we consider that nasal

washing with saline solution will be as effec-

tive as BTX-A injection if the correct technique is used.

REFERENCES

1. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effectof botulinum toxin type A on nasal symptoms in patientswith allergic rhinitis: a double-blind, placebo-controlledclinical trial. Acta Otolaryngol 2003; 123: 1060�/3.

2. Ozsoylu S. Nose drops at the common cold. Eur J Pediatr1985; 144: 294.

3. Karadag A. Nasal saline for acute sinusitis. Pediatrics2002; 109: 165.

4. Kurtaran H, Karadag A, Catal F, Avci Z. A reappraisalof nasal saline solution use in chronic sinusitis. Chest2003; 124: 2036�/7.

5. Georgitis JW. Nasal hyperthermia and simple irrigationfor perennial rhinitis. Changes in inflammatory media-tors. Chest 1994; 106: 1487�/92.

6. Pichichero ME, Green JL, Francis AB, Marsocci SM,Murphy ML. Outcomes after judicious antibiotic use forrespiratory tract infections seen in a private pediatricpractice. Pediatrics 2000; 105: 753�/9.

Submitted February 13, 2004; accepted March 4, 2004

Address for correspondence:Ahmet Karadag, MDHuzur MahCeyhun Atif Kansu Cad343/11 Nergiz ApTR-06460 BalgatAnkaraTurkeyTel.: �/90 312 212 62 62Fax: �/90 312 221 32 76E-mail: [email protected]

Acta Otolaryngol 2004; 124: 1240

# Taylor & Francis 2004. ISSN 0001-6489 DOI 10.1080/00016480410018223

Act

a O

tola

ryng

ol D

ownl

oade

d fr

om in

form

ahea

lthca

re.c

om b

y U

nive

rsity

of

Pitts

burg

h on

07/

07/1

4Fo

r pe

rson

al u

se o

nly.